Target intelligence / Profile preview

Gastric and intestinal pH balance

Molecular classification
Other
01

Overview

Gastric and intestinal pH balance refers to the tightly regulated acid–base environment of the stomach and intestines. In the stomach, highly acidic gastric juice (pH 1–3) is produced by parietal cells via the H,K-ATPase proton pump and is buffered by bicarbonate secreted by other cells[4]. Acid secretion is dynamically regulated in response to food intake and is controlled by neuroendocrine mediators including gastrin (stimulates acid when pH is high), histamine, acetylcholine, and somatostatin (inhibits acid secretion when pH is low)[1][2][3][4][5]. In the small and large intestines, pH is modulated by continued secretion of bicarbonate (from the pancreas and gut epithelial cells), fermentation by microbiota, and absorption of metabolic products. pH regulation is crucial for the activation of digestive enzymes, protection against pathogens, and proper nutrient absorption. Abnormalities in pH balance underlie many gastrointestinal diseases, and are the target of several classes of drugs, but pH balance itself is not a molecule, receptor, or defined molecular entity[2][3][4][5].

Other names
Gastric pH regulationIntestinal pH regulationGastrointestinal acid-base balance
02

Mechanism of action

Inhibition of H,K-ATPase to reduce acid secretion (e.g., omeprazole). Blockade of histamine H2 receptors to reduce acid secretion. Neutralization of gastric acid by chemical buffers (antacids). Suppression of gastrin and stimulation of somatostatin for acid inhibition.

03

Biological functions

Acid secretion (by parietal cells via H,K-ATPase)Alkali secretion (bicarbonate secretion by other gastric cells)Feedback regulation via endocrine and neurocrine signaling (e.g., gastrin, somatostatin, acetylcholine, histamine)Protection against pathogensEnabling enzymatic digestion
04

Disease associations

Ulcer formation (when pH regulation fails)Acid-related dyspepsiaInfections (if acid barrier is lost)Malabsorption and digestive enzyme dysfunctionOther gastrointestinal disorders
05

Safety considerations

Hypochlorhydria leading to infection riskHyperacidity causing ulcers and mucosal damageDisruption of nutrient digestion and microbiomeRebound acid hypersecretion after withdrawal of inhibitors
06

Interacting drugs

Proton pump inhibitors (e.g., omeprazole)

3 more in the full profile.

07

Biomarkers

Intragastric pH measurementGastrin levels (indicator of regulatory feedback)Somatostatin levels

Beyond the preview

Go deeper on Gastric and intestinal pH balance.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastric and intestinal pH balance.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call